FDA Inspection 1229268 — Vesta Pharmaceuticals, Inc.

Vesta Pharmaceuticals, Inc. — FEI 1819875

The FDA completed an inspection of Vesta Pharmaceuticals, Inc. on February 9, 2024 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 9, 2024
Fiscal Year
2024
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Indianapolis, IN (United States)

Citations

IDCFRDescription
1556221 CFR 111.260(l)(1)Batch record - quality control review; production
1564521 CFR 111.455(c)Hold - mix-up, contamination, deterioration
1596721 CFR 111.117(b)Quality control operations - calibration records